Pancreatic Cell News Volume 1.32 | Nov 30 2010

    0
    49

    Pancreatic Cell News 1.32, November 30, 2010.

    TOP STORY 

    Class IA Phosphatidylinositol 3-Kinase in Pancreatic Beta Cells Controls Insulin Secretion by Multiple Mechanisms  ShareThis
    Inhibition of class IA phosphatidylinositol 3-kinase, using a mouse model lacking the pik3r1 gene specifically in beta cells and the pik3r2 gene systemically, results in glucose intolerance and reduced insulin secretion in response to glucose. [Cell Metab]

    PluripotentWallchart_645x110

    SPECIAL FEATURES 

    Interested in recruiting talented individuals? Post your career opportunities in Pancreatic Cell News at no cost. Contact us at info@connexoncreative.com

    Follow us on Twitter! @PancreaticCell

    SCIENCE NEWS

    Type 1 Diabetes Mortality Rates Dropping
    Mortality rates for people with type 1 diabetes are decreasing, but overall remain seven times higher than those of the general population — likely as a result of long-term complications. [Press release from the American Diabetes Association discussing online prepublication in Diabetes Care]

    Request a Sample 
    Fast Isolation of Highly Purified Mouse B Cells
    with EasySep®
     
     
    REQUEST A SAMPLESTEMCELL Technologies Inc
     


    CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

    DIABETES

    Identification of 9-Cis-Retinoic Acid as a Pancreas-Specific Autacoid That Attenuates Glucose-Stimulated Insulin Secretion
    Data establish 9-cis-retinoic acid as a pancreas-specific autacoid with multiple mechanisms of action and provide unique insight into glucose-stimulated insulin secretion. [Proc Natl Acad Sci U S A]
     
    Long-Term In Vitro Human Pancreatic Islet Culture Using Three-Dimensional Microfabricated Scaffolds
    Researchers investigated the effects of human islet culture within various three-dimensional environments; collagen I gel, collagen I gel supplemented with extracellular matrix (ECM) components fibronectin and collagen IV, and microfabricated scaffold with ECM-supplemented gel. [Biomaterials]

    All-Cause Mortality Trends in a Large Population-Based Cohort with Long-Standing Childhood-Onset Type 1 Diabetes
    Although survival has clearly improved, those with diabetes diagnosed most recently (1975-1979) still had a mortality rate 5.6 times higher than that seen in the general population, revealing a continuing need for improvements in treatment and care, particularly for women and African Americans with type 1 diabetes. [Diabetes Care]

    Insulin Promoter DNA Methylation Correlates Negatively with Insulin Gene Expression and Positively with HbA1c Levels in Human Pancreatic Islets
    The study demonstrates that DNA methylation of the insulin promoter is increased in patients with type 2 diabetes and correlates negatively with insulin gene expression in human pancreatic islets. [Diabetologia]
     
    Dissociation of Lipotoxicity and Glucotoxicity in a Mouse Model of Obesity Associated Diabetes: Role of Forkhead Box O1 (FOXO1) in Glucose-Induced Beta Cell Failure
    Researchers used a sequential dietary regimen to dissociate the effects of obesity and hyperglycemia on beta cell function and integrity, and to study glucose-induced alterations of key transcription factors over 16 days. [Diabetologia]
     
    Co-Immobilization of Urokinase and Thrombomodulin on Islet Surfaces by Poly(Ethylene Glycol)-Conjugated Phospholipid
    Researchers propose a versatile method for modifying the surface of islets with the fibrinolytic enzyme urokinase and the soluble domain of the anticoagulant enzyme thrombomodulin. [J Control Release]

    PANCREATIC CANCER


    Continuous Cell Supply from a Sox9-Expressing Progenitor Zone in Adult Liver, Exocrine Pancreas and Intestine
    Researchers show that Sox9 is expressed throughout the biliary and pancreatic ductal epithelia, which are connected to the intestinal stem cell zone. [Nat Genet]

    Adaptive Unfolded Protein Response Attenuates Alcohol-Induced Pancreatic Damage
    Researchers investigated the role of X box-binding protein 1, an unfolded protein response regulator, in prevention of alcohol-induced endoplasmic reticulum stress in the exocrine pancreas. [Gastroenterology]
     
    miR-301a as an NF-KappaB Activator in Pancreatic Cancer Cells
    Researchers investigated whether microRNAs (miRNAs) contribute to NF-kappaB activation in pancreatic cancer. They demonstrated that miR-301a down-regulates NF-kappaB-repressing factor and elevates NF-kappaB activation. [EMBO J]

    Epithelial Dynamics of Pancreatic Branching Morphogenesis
    Results illustrate distinct, step-wise cellular mechanisms by which pancreatic epithelium shapes itself to create a functional branching organ. [Development]
     
    Plectin-1 as a Novel Biomarker for Pancreatic Cancer
    Plectin-1 is the first biomarker to identify primary and metastatic pancreatic cancer by imaging and may also detect preinvasive PanIN III lesions. [Clin Cancer Res]
     
    Ligand Stimulation of ErbB4 and a Constitutively-Active ErbB4 Mutant Result in Different Biological Responses in Human Pancreatic Tumor Cell Lines
    Researchers demonstrate that human pancreatic tumor cell lines exhibit minimal ErbB4 expression; in contrast, these cell lines exhibit varied and in some cases abundant expression and basal tyrosine phosphorylation of EGFR, ErbB2, and ErbB3. [Exp Cell Res]

    INDUSTRY NEWS

    Aetna Launches Diabetes Pilot with Medical Clinic of North Texas to Improve Health Outcomes of Hispanic and African American Patients
    Aetna announced a pilot with the Medical Clinic of North Texas aimed at improving the care of diabetic patients of Hispanic and African American descent. [Aetna Inc. Press Release]
     
    The NHS Technology Adoption Centre Launches Guide to Redress the Major Inequities Which Exist in the Provision of Diabetes Treatment
    The NHS Technology Adoption Centre has launched the How To Why To Guide on Insulin Pump Therapy and believes that this tool can help redress the inequities which currently exist in the treatment of type 1 diabetes. [Business Wire]

    POLICY NEWS

    National Institutes of Health (United States)

    Food and Drug Administration (United States)
     
    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)
     
    Medicines and Healthcare Products Regulatory Agency (United Kingdom)
     
    Therapeutic Goods Administration (Australia)

    EVENTS (Listed by Date)

    Pharmacology in Stem Cells Research and Regenerative Medicine
    December 17, 2010
    London, United Kingdom

    The 3rd Guangzhou International Conference on Stem Cell Biology and Regenerative Medicine
    December 17-19, 2010
    Guangzhou, China

    Type 2 Diabetes, Insulin Resistance and Metabolic Dysfunction
    January 12-17, 2011
    Dillon, United States

    Keystone Symposia: Obesity
    January 12-17, 2011
    Keystone, United States

    2011 Gastrointestinal Cancers Symposium
    January 20-22, 2011
    San Francisco, United States

    Keystone Symposia: Epithelial Plasticity and Epithelial to Mesenchymal Transition
    January 21-26, 2011
    Vancouver, Canada

    5th Annual Stem Cells and Regenerative Medicine World Congress
    January 24-25, 2011
    San Diego, United States

    Phacilitate 7th Annual Cell & Gene Therapy Forum 2011
    January 24-26, 2011
    Washington, D.C., United States

    Early Development for Innovative Diabetes & Metabolic Syndrome Therapeutics Conference
    January 26-27, 2011
    Amsterdam, The Netherlands

    Joint Conference of the International Association of Pancreatology and the Indian Pancreas Club
    February 10-13, 2011
    Maradu, India

    2nd Annual International Diabetes Summit
    February 22-24, 2011
    Dubai, United Arab Emirates

    NEW  World Cell Culture Congress 2011
    February 28-March 2, 2011
    Munich, Germany

    NEW PITTCON 2011
    March 13-18, 2011
    Atlanta, United States

    United Kingdom National Stem Cell Network 2011 Annual Scientific Conference
    March 30-April 1, 2011
    York, United Kingdom

    American Association for Cancer Research (AACR) 102nd Annual Meeting 2011
    April 2-6, 2011
    Orlando, United States

    NEW  World Stem Cells & Regenerative Medicine Congress 2011
    May 9-11, 2011
    London, United Kingdom

    13th Annual C21 BioVentures
    May 24-26, 2011
    Napa, United States

    Visit our events page  to stay up to date with the latest events in the cell, gene and immunotherapy community.


    JOB OPPORTUNITIES


    Lab Technologist – Human Embryonic and Induced Pluripotent Stem Cells (STEMCELL Technologies)

    Lab Technologist – Tissue Culture (STEMCELL Technologies)


    Recruit Top Talent

    Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News at no cost.

    Visit
    here to post your career opportunities.



    Have we missed an important article or publication in Pancreatic Cell News? Click here to submit!

     
    forwardafriendicon
     
    Comments or Suggestions? Email info@connexoncreative.com with your feedback.



    Learn more about Pancreatic Cell News: Archives | Events | Contact Us